Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Jun 2016 When Is Depression a Terminal Illness? Deliberative Suicide in Chronic Mental Illness Constance E. George, MD, MA In some cases, hope might not have substantial ethical or therapeutic value. AMA J Ethics. 2016;18(6):594-600. doi: 10.1001/journalofethics.2016.18.6.ecas4-1606. AMA Code Says Nov 2016 AMA Code of Medical Ethics’ Opinions Related to Discrimination and Disparities in Health Care Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics opinions related to discrimination and disparities in health care. AMA J Ethics. 2016;18(11):1095-1097. doi: 10.1001/journalofethics.2016.18.11.coet1-1611. Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612. Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612. State of the Art and Science Aug 2014 Use of Art Making in Treating Older Patients with Dementia Laura T. Safar, MD, MA A description of therapeutic applications of art making in the elderly population. Virtual Mentor. 2014;16(8):626-630. doi: 10.1001/virtualmentor.2014.16.8.stas1-1408.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Jun 2016 When Is Depression a Terminal Illness? Deliberative Suicide in Chronic Mental Illness Constance E. George, MD, MA In some cases, hope might not have substantial ethical or therapeutic value. AMA J Ethics. 2016;18(6):594-600. doi: 10.1001/journalofethics.2016.18.6.ecas4-1606.
AMA Code Says Nov 2016 AMA Code of Medical Ethics’ Opinions Related to Discrimination and Disparities in Health Care Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics opinions related to discrimination and disparities in health care. AMA J Ethics. 2016;18(11):1095-1097. doi: 10.1001/journalofethics.2016.18.11.coet1-1611.
Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612.
Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.
State of the Art and Science Aug 2014 Use of Art Making in Treating Older Patients with Dementia Laura T. Safar, MD, MA A description of therapeutic applications of art making in the elderly population. Virtual Mentor. 2014;16(8):626-630. doi: 10.1001/virtualmentor.2014.16.8.stas1-1408.